Gurjar O P, Arya R, Goyal H, Handa P, Bagdare P, Khan A, Paliwal R K, Mishra S P
Department of Radiotherapy, All India Institute of Medical Sciences, Bhopal.
Department of Physics, Mewar University, Chittorgarh.
J Biomed Phys Eng. 2019 Apr 1;9(2):151-160. eCollection 2019 Apr.
Craniospinal irradiation (CSI) of medulloblastoma poses technological challenges due to the involvement of large treatment volume. Commonly, the whole treatment length is covered with two different isocentric plans in which the junction is shifted after every five fractions to overcome the possibility of hot and cold spot.
This study aims to evaluate dosimetrically and clinically the innovative planning technique for the CSI which doesn't need re-planning and re-setup of patients after every five fractions.
Computed tomography was done for fifteen (ten children and five adults) patients diagnosed with medulloblastoma. Treatment planning for 36 Gray (Gy) in 20 fractions (#) at the rate of 1.8Gy/# was done on the treatment planning system. A single plan for children was created with two bilateral fields of 6 Mega Voltage (MV) energy for cranium and one posterior field of 6 MV for spinal cord (C1-S2). Two plans for adult patients were created, first plan was with two bilateral fields of 6 MV for cranium and two posterior oblique fields of 6 MV for cervical and the part of thoracic spinal cord (up to T8-T9). The second plan was with a single posterior field of 15 MV covering remaining thoracic (T8-T9 to T12), lumbar and sacrum (up to lower border of S2) spine. After careful evaluation of all the plans, treatment was delivered; acute toxicities were recorded.
95% of prescribed dose was received by more than 95% of planning target volume in all the plans with the acceptable hot spot and good homogeneity index. All the patients reported common radiation induced acute toxicities (headache, vomiting, weakness) during radiotherapy.
The new planning technique for CSI has acceptable dosimetric and acute clinical possibilities; therefore it can be used for CSI for improved homogeneous dose delivery.
由于髓母细胞瘤的治疗体积较大,对其进行颅脊髓照射(CSI)存在技术挑战。通常,整个治疗疗程采用两种不同的等中心计划覆盖,每隔五分次移动一次射野衔接处,以避免出现热点和冷点。
本研究旨在从剂量学和临床角度评估一种创新的CSI计划技术,该技术无需每隔五分次就对患者重新进行计划和摆位。
对15例(10例儿童和5例成人)诊断为髓母细胞瘤的患者进行了计算机断层扫描。在治疗计划系统上,以1.8Gy/分次的剂量率,分20次给予36格雷(Gy)的治疗计划。为儿童制定了一个单一计划,包括两个6兆伏(MV)能量的双侧野用于头颅,一个6MV的后野用于脊髓(C1-S2)。为成年患者制定了两个计划,第一个计划包括两个6MV的双侧野用于头颅,两个6MV的后斜野用于颈椎和部分胸段脊髓(至T8-T9)。第二个计划包括一个15MV的单一后野,覆盖其余胸段(T8-T9至T12)、腰段和骶段脊柱(至S2下缘)。在仔细评估所有计划后进行治疗,并记录急性毒性反应。
在所有计划中,超过95%的计划靶体积接受了95%的处方剂量,热点可接受,均匀性指数良好。所有患者在放疗期间均出现了常见的放射性急性毒性反应(头痛、呕吐、虚弱)。
新的CSI计划技术在剂量学和急性临床方面具有可接受性;因此,它可用于CSI以改善剂量均匀性。